Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Escherichia coli outer membrane receptors are specialized proteins, predominantly TonB-dependent receptors (TBDTs), that facilitate the active transport of essential nutrients across the outer membrane (UniProt, 2024). These receptors are vital for the uptake of iron-siderophore complexes, vitamin B12, and other large molecules that cannot pass through standard porin channels (PubMed, PMID: 28257454). Because iron is a limiting factor for bacterial growth during infection, these receptors play a crucial role in the pathogenesis of E. coli-related diseases such as urinary tract infections and sepsis (NCBI, 2022). In pharmacology, these receptors are targeted using the "Trojan horse" approach, where an antibacterial agent is linked to a siderophore to ensure high-efficiency uptake into the bacterium (PubMed, PMID: 31601559). Cefiderocol is a clinically approved siderophore cephalosporin that utilizes these receptors to overcome common resistance mechanisms like porin loss or efflux pump overexpression (DrugBank, 2024). The diversity of these receptors, including FhuA, FepA, and CirA, allows the bacteria to adapt to various host environments, but also provides multiple pathways for drug entry.
Siderophore-mediated active transport (Trojan horse strategy) where the drug mimics natural ligands to gain entry into the bacterial cell (PubMed, PMID: 31601559).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli outer membrane receptors (E. coli OMRs) (E. coli OMRs).